Brca mutation status in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: a pivotal role for treatment decision-making

HIGHLIGHTS

  • who: Francesco Pavese and collaborators from the Division of Oncological Gynecology, Department of Women`s and Children`s Health, Fondazione Policlinico AGemelli IRCCS, Rome, Italy Department of Molecular Medicine and Medical Biotechnology, Federico II University, Naples, Italy have published the Article: BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making, in the Journal: (JOURNAL)
  • what: Department also a atreferral (affected and non-affected) performour the breast screeningisprogram the institute . center for the treatment Overall, of ovarian cancer, therefore a large number of BRCA1/2 . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?